Molecular Oncology Programme, Cell Division and Cancer Group, Centro Nacional de Investigaciones Oncológicas Madrid, Spain.
Front Oncol. 2011 Dec 14;1:50. doi: 10.3389/fonc.2011.00050. eCollection 2011.
Aurora-A is a serine/threonine kinase that plays critical roles in centrosome maturation, spindle dynamics, and chromosome orientation and it is frequently over-expressed in human cancers. In this work, we show that Aurora-A interacts with the SUMO-conjugating enzyme UBC9 and co-localizes with SUMO1 in mitotic cells. Aurora-A can be SUMOylated in vitro and in vivo. Mutation of the highly conserved SUMOylation residue lysine 249 significantly disrupts Aurora-A SUMOylation and mitotic defects characterized by defective and multipolar spindles ensue. The Aurora-A(K249R) mutant has normal kinase activity but displays altered dynamics at the mitotic spindle. In addition, ectopic expression of the Aurora-A(K249R) mutant results in a significant increase in susceptibility to malignant transformation induced by the Ras oncogene. These data suggest that modification by SUMO residues may control Aurora-A function at the spindle and that deficiency of SUMOylation of this kinase may have important implications for tumor development.
极光激酶 A 是一种丝氨酸/苏氨酸激酶,在中心体成熟、纺锤体动态和染色体定向中发挥关键作用,并且在人类癌症中经常过表达。在这项工作中,我们表明极光激酶 A 与 SUMO 连接酶 UBC9 相互作用,并在有丝分裂细胞中与 SUMO1 共定位。极光激酶 A 可以体外和体内发生 SUMO 化。高度保守的 SUMO 化残基赖氨酸 249 的突变显着破坏极光激酶 A 的 SUMO 化,随后出现有缺陷和多极纺锤体为特征的有丝分裂缺陷。Aurora-A(K249R) 突变体具有正常的激酶活性,但在有丝分裂纺锤体上表现出改变的动力学。此外,Aurora-A(K249R) 突变体的异位表达导致对 Ras 癌基因诱导的恶性转化的易感性显着增加。这些数据表明,SUMO 残基的修饰可能控制纺锤体上的极光激酶 A 功能,并且该激酶的 SUMO 化缺陷可能对肿瘤发展具有重要意义。